Amended Current Report Filing (8-k/a)
September 10 2018 - 4:32PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K/A
(Amendment
No.1)
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported):
July 2, 2018
MEDICAL
TRANSCRIPTION BILLING, CORP.
(Exact name of registrant as specified in its charter)
Delaware
|
|
001-36529
|
|
22-3832302
|
(State or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
7
Clyde Road, Somerset, New Jersey, 08873
(Address of principal executive offices, zip code)
(732)
873-5133
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company [X]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [X]
Explanatory
Note
This
Amendment No. 1 (this “Amendment”) to the Form 8-K
of Medical Transcription
Billing, Corp. (the “Company” or “MTBC”), originally filed with the Securities and Exchange Commission
(“SEC”) on July 2, 2018 (the “Original Form 8-K”), is being filed by the Company for the purpose of amending
and supplementing Item 9.01 of the Original Form 8-K. This Amendment is being filed to provide the information required by Items
9.01(a) and (b) of Form 8-K and Rules 8-04 and 8-05 of Regulation S-X that was not previously filed with the Original Form 8-K,
as permitted by the rules of the SEC. Except as provided herein, the disclosures made in the Original Form 8-K remain unchanged.
Section 9 ― Financial Statements and Exhibits
Item
9.01
|
Financial
Statements and Exhibits
|
|
(a)
|
Financial
statements of businesses acquired
|
The
combined carve-out financial statements of the “Orion Target Businesses”, a carve-out of Orion HealthCorp, Inc., substantially
all of whose assets were acquired with an effective date of July 1, 2018, are filed as Exhibit 99.1 and 99.2 to this Form 8-K
and incorporated herein by this reference.
|
(b)
|
Pro
forma financial information
|
Pro
forma financial information with respect to the acquisitions of Orion Target Businesses and Washington Medical Billing, LLC is
filed as Exhibit 99.3 to this Form 8-K and incorporated herein by this reference.
SIGNATURE(S)
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, hereunto duly authorized.
|
Medical
Transcription Billing, Corp.
|
|
(Registrant)
|
|
|
|
|
By:
|
/s/
Stephen A. Snyder
|
|
|
Stephen
A. Snyder
|
|
|
Chief
Executive Officer
|
Date:
September 10, 2018
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Jun 2024 to Jul 2024
CareCloud (NASDAQ:MTBCP)
Historical Stock Chart
From Jul 2023 to Jul 2024